Table 3.
COSMIC | ClinVar | CIViC | Ensembl | 1000 genomes | OncoKB | DrugBank | ClinicalTrials.gov | DGIdb | Cancer gene census | reactome | ncbi | DoCM | ExAC | canSAR | TCGA | GeneView | KEGG | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genome version | + | + | + | + | + | + | ∼ | + | ||||||||||
Gene | + | + | + | + | + | + | ∼ | ∼ | + | + | + | + | + | + | + | + | ||
Chromosome | + | + | + | + | + | + | + | + | ∼ | + | ||||||||
DNA position | + | + | + | + | + | + | + | + | ∼ | + | ||||||||
RefSeq transcript | + | + | + | + | ∼ | + | ||||||||||||
RefSeq protein | ∼ | + | + | + | + | ∼ | + | |||||||||||
Somatic classification | ∼ | + | + | + | ∼ | + | + | + | ||||||||||
DNA sub & position | + | + | + | + | + | ∼ | + | ∼ | ∼ | + | ||||||||
Protein sub & position | + | + | + | + | + | + | + | ∼ | ∼ | + | ||||||||
Variant type | + | + | + | + | + | + | + | + | + | + | + | |||||||
Variant consequence | + | + | + | + | + | + | + | + | + | |||||||||
PMIDs | + | + | + | + | ∼ | + | + | ∼ | + | + | ||||||||
Cancer type | ∼ | + | + | + | ∼ | ∼ | + | + | + | + | + | |||||||
Biomarker class | + | ∼ | + | |||||||||||||||
Therapeutic context | + | + | ∼ | ∼ | ∼ | + | + | |||||||||||
Effect | + | + | ∼ | ∼ | + | |||||||||||||
Level of evidence | + | + | + | ∼ | + | |||||||||||||
Sublevel of evidence | + | ∼ | ||||||||||||||||
Pathway | ∼ | ∼ | + | + | + | |||||||||||||
Drug | + | + | ∼ | + | ||||||||||||||
Clinical significance | + | + | ||||||||||||||||
Molecular mechanism | + | |||||||||||||||||
Fully integrated | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||||
Specifically linked | + | + | + | + |
In some cases the information is provided only in part (’ ∼’), meaning that either references to other sources are provided which hold the needed information or that the information is provided only for a subset of entities